Archiv | Archiv 2018 | ESMO 2018

Welcome to Munich

ESMO 2018

Welcome to munich

Dr. med. Friedrich Overkamp

Kolorektales Karzinom

ESMO 2018

Adjuvante Therapie: Liquid Biopsy

Prof. Dr. med. Anke Reinacher-Schick

ESMO 2018

metastasiertes Analkarzinom

Prof. Dr. med. Dirk Arnold

ESMO 2018

CRC

PD Dr. med. Dominik Modest

ESMO 2018

Kolonkarzinom

Prof. Dr. med. Dirk Arnold

ESMO 2018

Adjuvante Therapie: Liquid Biopsy & MOSAIC trial

Prof. Dr. med. Anke Reinacher-Schick

ESMO 2018

VOLFI trial & NORDIC9

Prof. Dr. med. Anke Reinacher-Schick

Mammakarzinom

ESMO 2018

CDK4/6 QoL und OS Update

Prof. Dr. med. Peter Fasching

ESMO 2018

Alpelisib (ALP) + fulvestrant (FUL): SOLAR-1 trial

PD Dr. med. Hans-Christian Kolberg

ESMO 2018

PD-L1-doch wieder ein Marker?

Prof. Dr. med. Peter Fasching

ESMO 2018

SOLO 1

Prof. Dr. med. Peter Fasching

ESMO 2018

Update Quality of Life

PD Dr. med. Hans-Christian Kolberg

ESMO 2018

IMpassion130

Prof. Dr. med. Diana Lüftner

ESMO 2018

CDK 4/6 Update

Prof. Dr. med. Diana Lüftner

ESMO 2018

PALOMA 3 Update

PD Dr. med. Hans-Christian Kolberg

ESMO 2018

IMpassion130 atezolizumab + nab-paclitaxel in mTNBC

Prof. Dr. med. Peter Fasching

Melanom

ESMO 2018

CheckMate 511

Prof. Dr. med. Axel Hauschild

ESMO 2018

Update Combi-AD-Biomarker

Dr. med. Elisabeth Livingstone

ESMO 2018

Combi-AD

Prof. Dr. med. Axel Hauschild

ESMO 2018

Melanom - neoadjuvante Therapie: OpACIN-neo

Dr. med. Elisabeth Livingstone

ESMO 2018

Update Combi-AD-adjuvante Therapie

Dr. med. Elisabeth Livingstone

Urogenitale Tumoren

ESMO 2018

NMIBC KEYNOTE-057

Dr. med. Gerson Lüdecke

ESMO 2018

mUC CheckMate 032

Dr. med. Gerson Lüdecke

ESMO 2018

Nierenzellkarzinom JAVELIN Renal 101

Prof. Dr. med. Viktor Grünwald

Weitere

ESMO 2018

Nobelpreis Checkpoint Inhibitoren

Dr. med. Friedrich Overkamp

ESMO 2018

ASH 2018 Teaser

Dr. Friedrich Overkamp

ESMO 2018

SABCS 2018 Teaser

Dr. med. Friedrich Overkamp

ESMO 2018

Kopf-Hals-Tumoren

Prof. Dr. med. Viktor Grünwald